张同泰品牌怎么样 申请店铺

我要投票 张同泰在中医保健行业中的票数:655 更新时间:2026-02-13
张同泰是哪个国家的品牌?「张同泰」是 杭州张同泰药业有限公司 旗下著名品牌。该品牌发源于浙江,由创始人潘慧芳在2009期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力张同泰品牌出海!将品牌入驻外推网,定制张同泰品牌推广信息,可以显著提高张同泰产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

张同泰怎么样

张同泰,是清朝年间杭州老商号,始创于1805年,比胡庆余堂还要早70年左右,以其道地的中药材在江浙一带很有名气,2000年被列入杭州市文物保护单位。

创始人张梅,浙江慈溪人。清嘉庆五年(1800年)在杭州新宫桥下开设茂昌药号。嘉庆十年,盘进沈同泰药号而取名为张同泰。张同泰生产各种丸散,膏丹,药酒,在杭嘉湖一带享有盛名,和胡庆余堂,叶种德堂齐名号杭州三大药堂。民国元年,药店经大规模翻建后,新屋落成,重建石墙门,上刻“万象”商标。“张同泰”镀金大字熠熠生辉,大门两旁悬挂“张同泰道地药材”铜牌,自制传统成药360余种。首批进入商务部“老字号企业”。

杭州华东大药房连锁有限公司是杭州主要的大型医药零售连锁企业之一,隶属华东医药股份有限公司,具有独立法人地位。法人代表李邦良为全国十届人大代表、华东医药股份有限公司董事长。总部设在南宋御街中山中路323号,注册资本1500万元,经营中西成药,中药材,饮片配方,医疗器械等近2万余个品种,2008年销售1.08亿元。

公司是GSP质量认证企业,实行先进的计算机信息系统管理。现有门店22家,一个中医门诊部。全部列入市医保定点药店同时拥有五家省医保定点药店。门店中既有久负盛名的中华老字号,又有新型医药卖场,覆盖杭州主要城区,在市民中享有较高的信誉和知名度。

Zhang Tongtai, an old business name in Hangzhou during the Qing Dynasty, was founded in 1805, about 70 years earlier than Hu qingyutang. It is famous for its authentic Chinese medicinal materials in Jiangsu and Zhejiang. It was listed as a cultural relic protection unit in Hangzhou in 2000. Founder Zhang Mei, from Cixi, Zhejiang Province. In the fifth year of Jiaqing Dynasty (1800), Maochang medicine number was opened under the new palace bridge in Hangzhou. In the 10th year of Jiaqing, Pan Jin was named Zhang Tongtai after Shen Tongtai. Zhang Tongtai produces all kinds of pills, ointments and medicinal wine. He is famous in Hangjiahu area. He is as famous as Hu qingyutang and ye Zhongde Tang as the three medicine halls in Hangzhou. In the first year of the Republic of China, after the large-scale renovation of drugstores, the new house was completed, the stone wall door was rebuilt, and the "Vientiane" trademark was engraved on it. "Zhang Tongtai" gilded big characters are shining, and "Zhang Tongtai genuine herbs" bronze medals are hung on both sides of the gate, with more than 360 kinds of self-made traditional medicines. It is one of the first batch to enter the "time-honored enterprises" of the Ministry of Commerce. Hangzhou Huadong pharmacy chain Co., Ltd. is one of the major large-scale pharmaceutical retail chain enterprises in Hangzhou. It is subordinate to Huadong Pharmaceutical Co., Ltd. and has an independent legal person status. Li Bangliang, the legal representative, is the representative of the 10th National People's Congress and the chairman of East China Pharmaceutical Co., Ltd. Headquartered in No. 323, Zhongshan Middle Road, Yujie street, Southern Song Dynasty, with a registered capital of 15 million yuan, the company operates nearly 20000 varieties of Chinese and Western patent medicines, Chinese herbal medicines, decoction pieces, medical devices, etc., with a sales volume of 108 million yuan in 2008. GSP quality certification company, the implementation of advanced computer information system management. There are 22 stores and one TCM clinic. All of them are listed in the designated pharmacies of municipal medical insurance and have five designated pharmacies of provincial medical insurance at the same time. In the store, there are not only famous Chinese time-honored brands, but also new medicine stores, covering the main urban areas of Hangzhou, enjoying high reputation and popularity among the citizens.

本文链接: https://brand.waitui.com/30a3c39cf.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

热门中概股美股盘前多数下跌,理想汽车跌超1%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,京东、B站、腾讯音乐、理想汽车跌超1%,百度跌0.94%,蔚来跌0.79%,小鹏汽车跌0.77%,阿里巴巴跌0.74%,爱奇艺跌0.52%;网易涨近1%。

2小时前

翔鹭钨业:如钨精矿价格剧烈变化而钨制品价格未能同步变动,将对公司经营业绩产生影响

36氪获悉,翔鹭钨业公告,公司生产所需的钨精矿基本通过外购获得,公司产品的销售价格根据钨精矿价格变动情况相应调整,从而降低了原材料价格波动对公司经营业绩的影响,但如果未来钨精矿价格发生剧烈变化而钨制品价格未能同步变动,将会对公司主要产品的毛利率水平及经营业绩产生影响。

2小时前

中芯国际:存储器、BCD供不应求都在涨价

36氪获悉,中芯国际公告,在11月份业绩说明会上,有提到存储大周期对于产业和晶圆代工业的影响。在这样的市场环境下,公司凭借在BCD、模拟、存储、MCU、中高端显示驱动等细分领域中的技术储备与领先优势、客户的产品布局,在本轮行业发展周期中,仍能保持有利位置。公司将积极响应市场的紧急需求,推动2026年收入继续增长。价钱是一种供需的关系。中芯国际的存储器、BCD供不应求,都是在涨价的,友商部分成熟的产能不做了,市场上的供应量是在下降的。

2小时前

沪电股份:拟投资33亿元新建高端印制电路板生产项目

36氪获悉,沪电股份公告,公司于2026年2月11日召开的第八届董事会第十四次会议审议通过《关于新建高端印制电路板生产项目的议案》,同意投资新建“高端印制电路板生产项目”,生产高层数、高频高速、高密度互连、高通流PCB,以满足高速运算服务器、下一代高速网络交换机等对高端印制电路板的中长期增量需求。本项目总投资约为33亿元人民币,建成后预计年新增产能14万平方米高端印制电路板的生产规模,预计年新增营业收入30.5亿元人民币。

2小时前

引航生物递表港交所

36氪获悉,据港交所,苏州引航生物科技股份有限公司向港交所提交上市申请书,独家保荐人为华泰国际。

2小时前

本页详细列出关于张同泰的品牌信息,含品牌所属公司介绍,张同泰所处行业的品牌地位及优势。
咨询